SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2569[2250] Mild Renal Impairment as a Potential Prognostic Factor in Patients with SIan@SI-12/7/2005
2568[786] A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus MIan@SI-12/7/2005
2567[3336] An Outpatient Salvage Approach for Advanced Lymphoma Incorporating StratiIan@SI-12/7/2005
2566[2547] Bortezomib Continues Demonstrates Superior Efficacy Compared with High-DoIan@SI-12/7/2005
2565Low dose velcade, thalidomide and dexamethasone (LD-VTD): An effective regimen fIcebrg-12/4/2005
2564Combination of QUADRAMET(R) and Novel First-in-class Proteasome Inhibitor to be Icebrg-11/28/2005
2563[Tumor Lysis Syndrome After Bortezomib Therapy for Plasma Cell Leukemia] >&gtuck-11/26/2005
2562Evidently, he is the resident hedgehog expert at Millennium. Or was - I am not sIcebrg-11/23/2005
2561Erik, the "Expert Opinion" articles are usually written by neutral thituck-11/23/2005
2560Hedgehog and spinal cord injury. Expert Opin Ther Targets. 2005 Dec;9(6):1137-4Icebrg-11/23/2005
2559Looks like at least one analyst thinks MLNM will be profitable next year... <Ian@SI-11/18/2005
2558Should have been added to my previous post: (xii) 518 - -front line AML as singsoftware salesperson-11/17/2005
2557Thanks for your comments guys. There is substantial institutional/MF ownershipkeokalani'nui-11/17/2005
2556Dunsire has brought much-needed focus to the company. She seems to be a very ambIcebrg-11/17/2005
2555Wilder, I assume by “strategic alternative” you mean to be sold. Actually, thesoftware salesperson-11/17/2005
2554[NPI-0052, a novel orally active proteasome inhibitor induces apoptosis in MM cetuck-11/17/2005
2553If they are not, they had better start. Losing my patience I am..mopgcw-11/17/2005
2552Does anybody think mlnm BoD and Mgmt just might be ready to consider a strategikeokalani'nui-11/16/2005
2551Item 1.01 Entry into a Material Definitive Agreement. On November 7, 2005, Icebrg-11/14/2005
2550Public release date: 14-Nov-2005 Contact: Teresa Herbert teresa_herbert@dfci.haIan@SI-11/14/2005
2549[Velcade versus Graft Versus Host Disease] >>Blood. 2005 Nov 10; [Epub ahtuck-11/14/2005
2548Early Initiation Of INTEGRILIN(R) (Eptifibatide) for Heart-Attack Patients in EmIcebrg-11/12/2005
2547gs: Millennium Pharmaceuticals, Inc. (MLNM) MLNM(IL/N): Strategies set to achievmopgcw-11/4/2005
254611/2/05 analyst day highlights P 1 / 2 data V + Rev at Ash Updated Apex survisoftware salesperson-11/3/2005
2545Millennium Initiates Trial of Novel Aurora Kinase Inhibitor MLN8054 in Advanced mopgcw-11/3/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News